Albemarle started operations on April, 1st 2009 as Chemetall Lithium India Pvt. Ltd. The company was registered in December 2008 in New Delhi as a 100% owned subsidiary of Chemetall GmbH, Germany.
In 2010 the company moved to its present Mumbai location:
Rockwood Lithium India Pvt. Ltd.
103, Windfall, Sahar Plaza
J.B. Nagar, Andheri (East)
Mumbai 400 059
Phone: +91 22 6138 6138
Fax: +91 22 6138 6100
We have been a pioneer in India for over 20 years, starting with the supply of laboratory and pilot quantities to major organic synthesis projects. The company recently introduced several successful new products onto the Indian market.
Today, all major producers of active pharmaceutical ingredients, as well as numerous generic drug manufacturers are supplied in particular with the groups specialties and cesium compounds and Albemarle works closely together with research departments as well as the CROs (Contract Research Organization).
The pharmaceutical sector in India has been growing rapidly and has gained strong global market presence in cardio-vascular treatment drugs, as well as medicines for HIV treatment. This market should continue to grow, as more active ingredients come off patent and the recognized competitive edge of the Indian pharmaceutical industry is also of essential benefit for lowering the cost, as driven by NGOs.